| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.976 | 0.002 | 0.976 | Platelet aggregation inhibitor | 0.951 0.003 CID_173861 0.963 0.003 CID_174711 | ||
| 0.976 | 0.002 | 0.976 | Platelet activating factor antagonist | 0.94 0.002 CID_173861 0.96 0.002 CID_174711 | ||
| 0.958 | 0.003 | 0.958 | Anticonvulsant | 0.932 0.003 CID_173861 0.832 0.004 CID_174711 | ||
| 0.953 | 0.001 | 0.953 | Benzodiazepine agonist | 0.714 0.002 CID_173861 0.83 0.001 CID_174711 | ||
| 0.883 | 0.002 | 0.883 | GABA receptor agonist | 0.814 0.002 CID_173861 0.77 0.003 CID_174711 | ||
| 0.544 | 0.07 | 0.569 | Antiinflammatory | 0.569 0.062 CID_173861 0.293 0.222 CID_174711 | CID_173861 | |
| 0.389 | 0.004 | 0.389 | Uric acid excretion stimulant | 0.386 0.004 CID_173861 0.37 0.004 CID_174711 | ||
| 0.293 | 0.004 | 0.293 | Bromodomain-containing protein 4 inhibitor | 0.111 0.011 CID_173861 0.208 0.005 CID_174711 | ||
| 0.274 | 0.035 | 0.274 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.229 0.057 CID_173861 0.23 0.056 CID_174711 | ||
| 0.273 | 0.039 | 0.376 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.229 0.052 CID_173861 0.376 0.022 CID_174711 | CID_174711 | |
| 0.232 | 0.005 | 0.232 | Potassium channel activator | 0.134 0.026 CID_173861 0.18 0.012 CID_174711 | ||
| 0.223 | 0.003 | 0.223 | Bromodomain-containing protein 3 inhibitor | 0.099 0.005 CID_173861 0.195 0.003 CID_174711 | ||
| 0.29 | 0.074 | 0.29 | Spasmolytic | 0.251 0.091 CID_173861 | ||
| 0.215 | 0.038 | 0.215 | Protein kinase (CK1) gamma 1 inhibitor | 0.154 0.066 CID_173861 0.155 0.065 CID_174711 | ||
| 0.292 | 0.121 | 0.292 | GABA C receptor rho-3 antagonist | |||
| 0.21 | 0.069 | 0.248 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.185 0.089 CID_173861 0.248 0.052 CID_174711 | CID_174711 | |
| 0.147 | 0.009 | 0.147 | GABA A receptor antagonist | 0.078 0.022 CID_173861 0.061 0.03 CID_174711 | ||
| 0.187 | 0.049 | 0.187 | Protein kinase (CK1) gamma inhibitor | 0.131 0.08 CID_173861 0.124 0.086 CID_174711 | ||
| 0.136 | 0.01 | 0.136 | GABA receptor antagonist | 0.076 0.023 CID_173861 0.057 0.035 CID_174711 | ||
| 0.178 | 0.063 | 0.178 | Thrombolytic | 0.176 0.064 CID_173861 | ||
| 0.17 | 0.065 | 0.17 | Polo-like kinase-3 inhibitor | 0.153 0.081 CID_173861 | ||
| 0.113 | 0.029 | 0.113 | Interleukin 5 antagonist | 0.101 0.04 CID_173861 0.1 0.042 CID_174711 | ||
| 0.166 | 0.084 | 0.166 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.151 0.094 CID_173861 | ||
| 0.09 | 0.009 | 0.09 | Nicotinic acid receptor 1 agonist | 0.04 0.028 CID_173861 0.066 0.014 CID_174711 | ||
| 0.109 | 0.039 | 0.109 | Epidermal growth factor antagonist | 0.1 0.045 CID_173861 0.084 0.06 CID_174711 | ||
| 0.13 | 0.063 | 0.13 | Epidermal growth factor receptor kinase inhibitor | 0.116 0.077 CID_173861 | ||
| 0.124 | 0.062 | 0.124 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.1 | 0.04 | 0.1 | Bromodomain-containing protein 2 inhibitor | |||
| 0.085 | 0.029 | 0.085 | Purinergic P2 antagonist | |||
| 0.056 | 0.01 | 0.056 | Phenylethanolamine N methyltransferase inhibitor | 0.056 0.009 CID_173861 0.047 0.018 CID_174711 | ||
| 0.048 | 0.02 | 0.048 | Cholecystokinin A antagonist | |||
| 0.053 | 0.025 | 0.053 | 5 Hydroxytryptamine 2C agonist | |||
| 0.081 | 0.062 | 0.081 | GABA A receptor agonist | |||
| 0.03 | 0.019 | 0.03 | Vasopressin 1A antagonist | |||
| 0.037 | 0.028 | 0.041 | Oxytocin antagonist | 0.041 0.023 CID_173861 | CID_173861 | |
| 0.037 | 0.029 | 0.039 | Urate transporter 1 inhibitor | 0.039 0.027 CID_173861 | CID_173861 | |
| 0.1 | 0.093 | 0.1 | Interleukin 2 antagonist | |||
| 0.033 | 0.028 | 0.033 | Purinergic P2X7 antagonist | |||
| 0.163 | 0.16 | 0.163 | Streptokinase A inhibitor | |||
| 0.127 | 0.125 | 0.127 | LIM domain kinase 1 inhibitor | |||
| 0.034 | 0.033 | 0.034 | Cholecystokinin antagonist | |||
| 0.215 | 0.213 | 0.215 | Transcription factor inhibitor | |||
| 0.097 | 0.109 | 0.126 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.126 0.08 CID_174711 | CID_174711 | |
| 0.166 | 0.187 | 0.2 | 12-Lipoxygenase inhibitor | 0.2 0.151 CID_173861 | CID_173861 | |
| 0.088 | 0.148 | 0.171 | Protein kinase C nu inhibitor | 0.171 0.059 CID_174711 | CID_174711 | |
| 0.017 | 0.141 | 0.042 | Benzodiazepine receptor peripheral-type antagonist | 0.042 0.012 CID_174711 | CID_174711 | |
| 0.069 | 0.288 | 0.133 | Platelet adhesion inhibitor | 0.133 0.128 CID_173861 | CID_173861 | |
| 0.107 | 0.459 | 0.267 | Cyclophilin D inhibitor | 0.267 0.194 CID_173861 | CID_173861 | |
| 0.001 | 0.983 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.015 CID_174711 | CID_174711 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |